WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer.

INTRODUCTION WNT5A belongs to the Wnt family of secreted signaling molecules. Using transcriptional profiling, we previously identified WNT5A as target of the antiapoptotic transcription factor CUX1 and demonstrated high expression levels in pancreatic cancer. However, the impact of WNT5A on drug resistance and the signaling pathways employed by WNT5A remain to be elucidated. OBJECTIVES This project aims to decipher the impact of WNT5A on resistance to apoptosis and the signaling pathways employed by WNT5A in pancreatic cancer. METHODS The impact of WNT5A and its downstream effectors on tumor growth and drug resistance was studied in vitro and in xenograft models in vivo. Tissue microarrays of pancreatic cancer specimens were employed for immunohistochemical studies. RESULTS Knockdown of WNT5A results in a significant increase in drug-induced apoptosis. In contrast, overexpression of WNT5A or addition of recombinant WNT5A mediates resistance to apoptosis in vitro. In our attempt to identify downstream effectors of WNT5A, we identified the transcription factor nuclear factor of activated T cells c2 (NFATc2) as transcriptional target of WNT5A signaling. NFATc2 confers a strong antiapoptotic phenotype mediating at least in part the effects of WNT5A on drug resistance and tumor cell survival. In vivo, WNT5A expression leads to resistance to gemcitabine-induced apoptosis in a xenograft model, which is paralleled by up-regulation of NFATc2. Both WNT5A and NFATc2 proteins are highly expressed in human pancreatic cancer tissues and their expression levels correlated significantly. CONCLUSION We identified the WNT5A-NFATc2 axis as important mediator of drug resistance in pancreatic cancer.

[1]  M. Fresno,et al.  TNF-α Contributes to Caspase-3 Independent Apoptosis in Neuroblastoma Cells: Role of NFAT , 2011, PloS one.

[2]  D. Richel,et al.  Targeting Wnt Signaling in Colon Cancer Stem Cells , 2010, Clinical Cancer Research.

[3]  Hongli Yu,et al.  Wnt5a as a Predictor in Poor Clinical Outcome of Patients and a Mediator in Chemoresistance of Ovarian Cancer , 2010, International Journal of Gynecologic Cancer.

[4]  Chien-Chang Chen,et al.  Activation of a nuclear factor of activated T‐lymphocyte‐3 (NFAT3) by oxidative stress in carboplatin‐mediated renal apoptosis , 2010, British journal of pharmacology.

[5]  V. Ellenrieder,et al.  NFAT transcription factors, the potion mediating "Dr. Jekyll-Mr. Hyde" transformation of the TGFβ pathway in cancer cells , 2010, Cell cycle.

[6]  Q. Tao,et al.  WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma , 2010, Cancer biology & therapy.

[7]  E. Bradley,et al.  WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. , 2010, Molecular endocrinology.

[8]  T. Phang,et al.  Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl. , 2010, Cancer cell.

[9]  O. Fromigué,et al.  Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium Ranelate* , 2010, The Journal of Biological Chemistry.

[10]  Y. Minami,et al.  Cell/tissue-tropic Functions of Wnt5a Signaling in Normal and Cancer Cells , 2022 .

[11]  R. Poulsom,et al.  CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer , 2010, Gut.

[12]  J. Viola,et al.  Melatonin Protects CD4+ T Cells from Activation-Induced Cell Death by Blocking NFAT-Mediated CD95 Ligand Upregulation , 2010, The Journal of Immunology.

[13]  T. Gress,et al.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells. , 2010, Gastroenterology.

[14]  Jose Cervera,et al.  Epigenetic regulation of the non‐canonical Wnt pathway in acute myeloid leukemia , 2010, Cancer science.

[15]  M. Hetman,et al.  Nuclear Factor of Activated T-Cells Isoform c4 (NFATc4/NFAT3) as a Mediator of Antiapoptotic Transcription in NMDA Receptor-Stimulated Cortical Neurons , 2009, The Journal of Neuroscience.

[16]  A. Toker,et al.  NFAT proteins: emerging roles in cancer progression , 2009, Nature Reviews Cancer.

[17]  A. Silver,et al.  The opposing roles of Wnt-5a in cancer , 2009, British Journal of Cancer.

[18]  N. Kaminski,et al.  WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. , 2009, American journal of respiratory cell and molecular biology.

[19]  J. Viola,et al.  Dual Roles for NFAT Transcription Factor Genes as Oncogenes and Tumor Suppressors , 2008, Molecular and Cellular Biology.

[20]  Linda Potter,et al.  WNT5A Expression Increases during Melanoma Progression and Correlates with Outcome , 2008, Clinical Cancer Research.

[21]  E. Duan,et al.  Effects of Wnt proteins on cell proliferation and apoptosis in HEK293 cells , 2008, Cell biology international.

[22]  Stephen N. Jones,et al.  Noncanonical Wnt signaling promotes apoptosis in thymocyte development , 2007, The Journal of experimental medicine.

[23]  J. Downward,et al.  WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. , 2007, Carcinogenesis.

[24]  T. Asahara,et al.  Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. , 2006, Cancer research.

[25]  R. Nusse,et al.  Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors* , 2006, Journal of Biological Chemistry.

[26]  T. Gress,et al.  Overexpression of c‐myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway , 2006, The EMBO journal.

[27]  T. Andersson,et al.  Wnt-5a/Ca2+-Induced NFAT Activity Is Counteracted by Wnt-5a/Yes-Cdc42-Casein Kinase 1α Signaling in Human Mammary Epithelial Cells , 2006, Molecular and Cellular Biology.

[28]  R. Nusse,et al.  Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context , 2006, PLoS biology.

[29]  M. Almeida,et al.  Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT* , 2005, Journal of Biological Chemistry.

[30]  T. Andersson,et al.  Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. , 2005, Cancer research.

[31]  C. D'Arrigo,et al.  CUTL1 is a target of TGFβ signaling that enhances cancer cell motility and invasiveness , 2005 .

[32]  G. Brabant,et al.  Wnt-5a has tumor suppressor activity in thyroid carcinoma , 2005, Oncogene.

[33]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[34]  A. Bradley,et al.  Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. , 2003, Cancer cell.

[35]  Christopher C. W. Hughes,et al.  Endothelial Cells Stimulate T Cell NFAT Nuclear Translocation in the Presence of Cyclosporin A: Involvement of the wnt/Glycogen Synthase Kinase-3β Pathway1 , 2002, The Journal of Immunology.

[36]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[37]  Katsuhiko Mikoshiba,et al.  The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos , 2002, Nature.

[38]  M. Katoh,et al.  Frequent up-regulation of WNT5A mRNA in primary gastric cancer. , 2002, International journal of molecular medicine.

[39]  T. Kadowaki,et al.  Drosophila Segment Polarity Gene Product Porcupine Stimulates the Posttranslational N-Glycosylation of Wingless in the Endoplasmic Reticulum* , 2002, The Journal of Biological Chemistry.

[40]  M. Bittner,et al.  Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. , 2002, Cancer cell.

[41]  C. Strathdee,et al.  Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. , 1999, Gene.

[42]  M. Oshimura,et al.  Ectopic Expression of wnt-5a in Human Renal Cell Carcinoma Cells Suppresses in vitro Growth and Telomerase Activity , 1998, Tumor Biology.

[43]  D. Olson,et al.  Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. , 1998, Experimental cell research.

[44]  R. Moon,et al.  Activities of the Wnt-1 class of secreted signaling factors are antagonized by the Wnt-5A class and by a dominant negative cadherin in early Xenopus development , 1996, The Journal of cell biology.

[45]  R. Iozzo,et al.  Aberrant expression of the growth factor Wnt-5A in human malignancy. , 1995, Cancer research.

[46]  J. Lloreta,et al.  New pancreas cancers cell lines that represent distinct stages of ductal differentiation. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[47]  A. Harris,et al.  Wnt5a cloning, expression, and up-regulation in human primary breast cancers. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  A. McMahon,et al.  Differential transformation of mammary epithelial cells by Wnt genes , 1994, Molecular and cellular biology.

[49]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[50]  T. Andersson,et al.  2 -Induced NFAT Activity Is Counteracted by Wnt-5a/Yes-Cdc42-Casein Kinase 1 (cid:2) Signaling in Human Mammary Epithelial Cells , 2006 .